Home / Executive Moves / Robert Leduc Appointed President of UTC’s Pratt & Whitney Unit; Gregory Hayes Comments

Robert Leduc Appointed President of UTC’s Pratt & Whitney Unit; Gregory Hayes Comments

UTClogoRobert Leduc, a 35-year veteran of United Technologies Corp. (NYSE: UTX), has been named president of UTC’s aircraft engine unit Pratt & Whitney.

He will succeed Paul Adams, who has led the business since 2014 and will retire by the end of February after a 17-year career at UTC, the company said Thursday.

Leduc is a former president at helicopter manufacturing business Sikorsky Aircraft, which Lockheed Martin (NYSE: LMT) bought from UTC through a $9 billion transaction that closed in November 2015.

“His vision and experience in the aerospace industry, his proven leadership skills and his track record of executing complex development programs make him the right choice to lead Pratt & Whitney, ” said Gregory Hayes, UTC president and CEO.

Leduc also previously served as chief operating officer at Pratt & Whitney and led the organization’s large commercial engines division as well as managed space systems business and Boeing (NYSE: BA) programs within UTC’s aerospace segment.

Additionally, David Hess, a UTC senior vice president, has been promoted to executive vice president and chief customer officer for the aerospace segment.

Hess will collaborate with Leduc and Dave Gitlin, president of UTC’s aerospace systems unit, in efforts to create value for the company’s partners and customers.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.